{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T04:43:51Z","timestamp":1775969031169,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s43032-022-01091-x","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T20:03:15Z","timestamp":1664481795000},"page":"1133-1142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Live Birth Rates in Women Under 38 Years Old with AMH Level\u2009&lt;\u20091.2\u00a0ng\/ml in the First In Vitro Fertilization\u2009+\u2009\/\u2009\u2212\u2009Intracytoplasmic Sperm Injection: Retrospective Study and Arguments for Care"],"prefix":"10.1007","volume":"30","author":[{"given":"Karine","family":"Morcel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0184-0880","authenticated-orcid":false,"given":"Philippe","family":"Merviel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Pertuisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pandora","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bou\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Le Guillou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Chabaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hortense","family":"Drapier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurore","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Beauvillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"1091_CR1","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10815-014-0328-7","volume":"31","author":"DB Seifer","year":"2014","unstructured":"Seifer DB, Merhi Z. Is AMH a regulator of follicular atresia? J Assist Reprod Genet. 2014;31:1403\u20137.","journal-title":"J Assist Reprod Genet"},{"key":"1091_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20:370\u201385.","journal-title":"Hum Reprod Update"},{"key":"1091_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/molehr\/gat024","volume":"19","author":"JV Jeppesen","year":"2013","unstructured":"Jeppesen JV, Anderson RA, Kelsey TW, Christiansen SL, Kristensen SG, Jayaprakasan K, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19:519\u201327.","journal-title":"Mol Hum Reprod"},{"key":"1091_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tem.2008.08.002","volume":"19","author":"FJ Broekmans","year":"2008","unstructured":"Broekmans FJ, Visser JA, Laven JSE, Broer SL, Themmen APN, Fauser BC. AntiM\u00fcllerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008;19:340\u20137.","journal-title":"Trends Endocrinol Metab"},{"key":"1091_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","volume":"11","author":"IAJ van Rooij","year":"2004","unstructured":"van Rooij IAJ, den Tonkelaar I, Broekmans FJM, Looman CWN, Scheffer GJ, de Jong FH, et al. Anti-m\u00fcllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause. 2004;11:601\u20136.","journal-title":"Menopause"},{"key":"1091_CR6","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1210\/jc.2018-00724","volume":"103","author":"M Depmann","year":"2018","unstructured":"Depmann M, Eijkemans MJC, Broer SL, Tehrani FR, Solaymani-Dodaran M, Azizi F, et al. Does AMH relate to timing of menopause? Results of an individual patient data meta-analysis. J Clin Endocrinol Metab. 2018;103:3593\u2013600.","journal-title":"J Clin Endocrinol Metab"},{"key":"1091_CR7","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616\u201324.","journal-title":"Hum Reprod"},{"key":"1091_CR8","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.12688\/f1000research.10382.1","volume":"5","author":"P Humaidan","year":"2016","unstructured":"Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of \u201clow prognosis patients in assisted reproductive technology\u201d and its proposed marker of successful outcome. F1000Research. 2016;5:2911.","journal-title":"F1000Research"},{"key":"1091_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113\u201330.","journal-title":"Hum Reprod Update"},{"key":"1091_CR10","doi-asserted-by":"publisher","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","volume":"6","author":"TW Kelsey","year":"2011","unstructured":"Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WHB. A validated model 42 of serum anti-m\u00fcllerian hormone from conception to menopause. PLoS One. 2011;6:e22024. https:\/\/doi.org\/10.1371\/journal.pone.0022024.","journal-title":"PLoS One"},{"key":"1091_CR11","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/oxfordjournals.humrep.a137570","volume":"7","author":"MJ Faddy","year":"1992","unstructured":"Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod Oxf Engl. 1992;7:1342\u20136.","journal-title":"Hum Reprod Oxf Engl"},{"key":"1091_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00439-013-1309-0","volume":"132","author":"E Fragouli","year":"2013","unstructured":"Fragouli E, Alfarawati S, Spath K, Jaroudi S, Sarasa J, Enciso M, et al. The origin and impact of embryonic aneuploidy. Hum Genet. 2013;132:1001\u201313.","journal-title":"Hum Genet"},{"key":"1091_CR13","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1515\/cclm-2014-0022","volume":"52","author":"D Gassner","year":"2014","unstructured":"Gassner D, Jung R. First fully automated immunoassay for anti-M\u00fcllerian hormone. Clin Chem Lab Med. 2014;52:1143\u201352.","journal-title":"Clin Chem Lab Med"},{"key":"1091_CR14","unstructured":"World Health Organization. WHO laboratory manual for the examination and processing of human semen. Fifth Edition. Geneva: WHO Press; 2010."},{"key":"1091_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0015-0282(00)01741-6","volume":"75","author":"P Terriou","year":"2001","unstructured":"Terriou P, Sapin C, Giorgetti C, Hans E, Spach JL, Roulier R. Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age. Fertil Steril. 2001;75:525\u201331.","journal-title":"Fertil Steril"},{"key":"1091_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dex208","volume":"32","author":"P Humaidan","year":"2017","unstructured":"Humaidan P, Chin W, Rogoff D, D\u2019Hooghe T, Longobardi S, Hubbard J, et al. Efficacy and safety of follitropin alfa\/lutropin alfa in ART: a randomized controlled trial in poor responders. Hum Reprod. 2017;32:544\u201355.","journal-title":"Hum Reprod"},{"key":"1091_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humupd\/dms041","volume":"19","author":"SL Broer","year":"2013","unstructured":"Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26\u201336.","journal-title":"Hum Reprod Update"},{"key":"1091_CR18","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1210\/jc.2013-1393","volume":"98","author":"S Iliodromiti","year":"2013","unstructured":"Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-M\u00fcllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab. 2013;98:3332\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"1091_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","volume":"103","author":"R Tal","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ, Seifer DB. Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103:119-30.e3.","journal-title":"Fertil Steril"},{"key":"1091_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.rbmo.2013.09.017","volume":"28","author":"K \u0141ukaszuk","year":"2014","unstructured":"\u0141ukaszuk K, Kunicki M, Liss J, Bednarowska A, Jakiel G. Probability of live birth in women with extremely low anti-M\u00fcllerian hormone concentrations. Reprod Biomed Online. 2014;28:64\u20139.","journal-title":"Reprod Biomed Online"},{"key":"1091_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/09513590.2018.1505850","volume":"35","author":"O Sefrioui","year":"2019","unstructured":"Sefrioui O, Madkour A, Aboulmaouahib S, Kaarouch I, Louanjli N. Women with extreme low AMH values could have in vitro fertilization success. Gynecol Endocrinol. 2019;35:170\u20133.","journal-title":"Gynecol Endocrinol"},{"key":"1091_CR22","first-page":"185","volume":"12","author":"N Pereira","year":"2016","unstructured":"Pereira N, Setton R, Petrini AC, Lekovich JP, Elias RT, Spandorfer SD. Is anti-M\u00fcllerian hormone associated with IVF outcomes in young patients with diminished ovarian reserve? Womens Health. 2016;12:185\u201392.","journal-title":"Womens Health"},{"key":"1091_CR23","doi-asserted-by":"publisher","first-page":"7279","DOI":"10.12659\/MSM.910410","volume":"24","author":"Y Chang","year":"2018","unstructured":"Chang Y, Li J, Li X, Liu H, Liang X. Egg quality and pregnancy outcome in young infertile women with diminished ovarian reserve. Med Sci Monit. 2018;24:7279\u201384.","journal-title":"Med Sci Monit"},{"key":"1091_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.rbmo.2010.11.005","volume":"22","author":"A La Marca","year":"2011","unstructured":"La Marca A, Nelson SM, Sighinolfi G, Manno M, Baraldi E, Roli L, et al. Anti-M\u00fcllerian hormone-based prediction model for a live birth in assisted reproduction. Reprod Biomed Online. 2011;22:341\u20139.","journal-title":"Reprod Biomed Online"},{"key":"1091_CR25","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/humrep\/dey238","volume":"33","author":"SJ Morin","year":"2018","unstructured":"Morin SJ, Patounakis G, Juneau CR, Neal SA, Scott RT, Seli E. Diminished ovarian reserve and poor response to stimulation in patients < 38 years old: a quantitative but not qualitative reduction in performance. Hum Reprod. 2018;33:1489\u201398.","journal-title":"Hum Reprod"},{"key":"1091_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.rbmo.2018.03.015","volume":"37","author":"A Pacheco","year":"2018","unstructured":"Pacheco A, Cruz M, Iglesias C, Garc\u00eda-Velasco JA. Very low anti-m\u00fcllerian hormone concentrations are not an independent predictor of embryo quality and pregnancy rate. Reprod Biomed Online. 2018;37:113\u20139.","journal-title":"Reprod Biomed Online"},{"key":"1091_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10815-016-0675-7","volume":"33","author":"A Revelli","year":"2016","unstructured":"Revelli A, Biasoni V, Gennarelli G, Canosa S, Dalmasso P, Benedetto C. IVF results in patients with very low serum AMH are significantly affected by chronological age. J Assist Reprod Genet. 2016;33:603\u20139.","journal-title":"J Assist Reprod Genet"},{"key":"1091_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/COCRM.1000301","volume":"6","author":"P Merviel","year":"2020","unstructured":"Merviel P, Jacamon AS, Bou\u00e9e S, Le Martelot MT, Roche S, Chabaud JJ, et al. Effects of female body mass index on the outcome of in vitro fertilization\/intracytoplasmic sperm injection or intrauterine insemination. Clin Obstet Gynecol Reprod Med. 2020;6:1\u201313. https:\/\/doi.org\/10.15761\/COCRM.1000301.","journal-title":"Clin Obstet Gynecol Reprod Med"},{"key":"1091_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","volume":"14","author":"DN Lekamge","year":"2007","unstructured":"Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist RB, Tremellen KP. Anti-M\u00fcllerian hormone as a predictor of IVF outcome. Reprod Biomed Online. 2007;14:602\u201310.","journal-title":"Reprod Biomed Online"},{"key":"1091_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0015-0282(02)04840-9","volume":"79","author":"JP Toner","year":"2003","unstructured":"Toner JP. Age = egg quality, FSH level = egg quantity. Fertil Steril. 2003;79:491.","journal-title":"Fertil Steril"},{"key":"1091_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.gyobfe.2015.09.014","volume":"44","author":"M Dercourt","year":"2016","unstructured":"Dercourt M, Barriere P, Freour T. High doses of gonadotropins for controlled ovarian hyperstimulation: a case-control study. Gynecol Obstet Fertil. 2016;44:29\u201334.","journal-title":"Gynecol Obstet Fertil"},{"key":"1091_CR32","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/humrep\/dew027","volume":"31","author":"L Webber","year":"2016","unstructured":"European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, Anderson R, Bartlett J, Braat D, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod Oxf Engl. 2016;31:926\u201337.","journal-title":"Hum Reprod Oxf Engl"},{"key":"1091_CR33","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1093\/humrep\/der240","volume":"26","author":"D Pu","year":"2011","unstructured":"Pu D, Wu J, Liu J. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. Hum Reprod. 2011;26:2742\u20139.","journal-title":"Hum Reprod"},{"key":"1091_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/09513590.2011.579206","volume":"28","author":"T Madani","year":"2012","unstructured":"Madani T, Ashrafi M, Yeganeh LM. Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: a retrospective study. Gynecol Endocrinol. 2012;28:102\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"1091_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12978-015-0039-2","volume":"12","author":"P Merviel","year":"2015","unstructured":"Merviel P, Cabry-Goubet R, Lourdel E, Devaux A, Belhadri-Mansouri N, Copin H, et al. Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy. Reprod Health. 2015;12:52. https:\/\/doi.org\/10.1186\/s12978-015-0039-2.","journal-title":"Reprod Health"},{"key":"1091_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejogrb.2018.05.032","volume":"227","author":"DT Fujii","year":"2018","unstructured":"Fujii DT, Quesnell JL, Heitmann RJ. Conversion to IUI versus continuance with IVF in low responder patients: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2018;227:35\u201340.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1091_CR37","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s13063-018-2936-5","volume":"19","author":"L Delbos","year":"2018","unstructured":"Delbos L, Parot-Schinkel E, El Hachem H, Legendre G, Descamps P, Boucret L, et al. ConFIRM trial \u2014 conversion of in vitro fertilization cycles to intrauterine inseminations in patients with a poor ovarian response to stimulation: a protocol for a multicentric, prospective randomized trial. Trials. 2018;19:565. https:\/\/doi.org\/10.1186\/s13063-018-2936-5.","journal-title":"Trials"},{"key":"1091_CR38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/oxfordjournals.humrep.a136959","volume":"4","author":"T Tanbo","year":"1989","unstructured":"Tanbo T, Dale PO, \u00c5byholm T, Stokke KT. Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate\/human menopausal gonadotrophin-stimulated cycles for in-vitro fertilization. Hum Reprod. 1989;4:647\u201350.","journal-title":"Hum Reprod"},{"key":"1091_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jgyn.2011.06.001","volume":"41","author":"F Lamazou","year":"2012","unstructured":"Lamazou F, Fuchs F, Grynberg M, Gallot V, Herzog E, Fanchin R, et al. Cancellation of IVF-ET cycles: poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimulation? An analysis of 142 cancellations. J Gyn\u00e9cologie Obst\u00e9trique Biol Reprod. 2012;41:41\u20137.","journal-title":"J Gyn\u00e9cologie Obst\u00e9trique Biol Reprod"},{"key":"1091_CR40","doi-asserted-by":"publisher","first-page":"723.e9","DOI":"10.1016\/j.fertnstert.2007.03.084","volume":"89","author":"T Fraisse","year":"2008","unstructured":"Fraisse T, Ibecheole V, Streuli I, Bischof P, de Ziegler D. Undetectable serum anti-M\u00fcllerian hormone levels and occurrence of ongoing pregnancy. Fertil Steril. 2008;89:723.e9-723.e11.","journal-title":"Fertil Steril"},{"key":"1091_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12958-019-0452-4","volume":"17","author":"AG Grynnerup","year":"2019","unstructured":"Grynnerup AG, L\u00f8ssl K, Pilsgaard F, Lunding SA, Storgaard M, Bogstad JW, et al. Prediction of the lower serum anti-M\u00fcllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys\u00ae AMH assay: a prospective observational study. Reprod Biol Endocrinol. 2019;17:11. https:\/\/doi.org\/10.1186\/s12958-019-0452-4.","journal-title":"Reprod Biol Endocrinol"},{"key":"1091_CR42","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","volume":"30","author":"Z Merhi","year":"2013","unstructured":"Merhi Z, Zapantis A, Berger DS, Jindal SK. Determining an anti-mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve. J Assist Reprod Genet. 2013;30:1361\u20135.","journal-title":"J Assist Reprod Genet"},{"key":"1091_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5152\/jtgga.2012.28","volume":"13","author":"MF Mutlu","year":"2012","unstructured":"Mutlu MF, Erdem A. Evaluation of ovarian reserve in infertile patients. J Turk Ger Gynecol Assoc. 2012;13:196\u2013203.","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"1091_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","volume":"91","author":"SL Broer","year":"2009","unstructured":"Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705\u201314.","journal-title":"Fertil Steril"},{"key":"1091_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12958-019-0497-4","volume":"17","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xu Y, Xue Q, Shang J, Yang X, Shan X, et al. Discordance between antral follicle counts and anti-M\u00fcllerian hormone levels in women undergoing in vitro fertilization. Reprod Biol Endocrinol. 2019;17:51. https:\/\/doi.org\/10.1186\/s12958-019-0497-4.","journal-title":"Reprod Biol Endocrinol"},{"key":"1091_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/humrep\/deh663","volume":"20","author":"ER Klinkert","year":"2005","unstructured":"Klinkert ER, Broekmans FJM, Looman CWN, Habbema JDF, te Velde ER. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod. 2005;20:611\u20135.","journal-title":"Hum Reprod"},{"key":"1091_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.fertnstert.2018.03.031","volume":"110","author":"VL Baker","year":"2018","unstructured":"Baker VL, Gracia C, Glassner MJ, Schnell VL, Doody K, Coddington CC, et al. Multicenter evaluation of the access AMH antim\u00fcllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2018;110:506-13.e3.","journal-title":"Fertil Steril"},{"key":"1091_CR48","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/humrep\/dev127","volume":"30","author":"J van Helden","year":"2015","unstructured":"van Helden J, Weiskirchen R. Performance of the two new fully automated anti-M\u00fcllerian hormone immunoassays compared with the clinical standard assay. Hum Reprod. 2015;30:1918\u201326.","journal-title":"Hum Reprod"},{"key":"1091_CR49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.clinbiochem.2015.10.008","volume":"49","author":"E Anckaert","year":"2016","unstructured":"Anckaert E, \u00d6ktem M, Thies A, Cohen-Bacrie M, Daan NMP, Schiettecatte J, et al. Multicenter analytical performance evaluation of a fully automated anti-M\u00fcllerian hormone assay and reference interval determination. Clin Biochem. 2016;49:260\u20137.","journal-title":"Clin Biochem"},{"key":"1091_CR50","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/jc.2012-1558","volume":"97","author":"F Raffi","year":"2012","unstructured":"Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:3146\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"1091_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5114\/aoms.2011.22084","volume":"2","author":"M Nichi","year":"2011","unstructured":"Nichi M, de Cassia S\u00e1vioFigueira R, de Ferreira Braga DPA, Setti AS, Iaconelli A Jr, Borges E Jr. Decreased fertility in poor responder women is not related to oocyte morphological status. Arch Med Sci. 2011;2:315\u201320.","journal-title":"Arch Med Sci"},{"key":"1091_CR52","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.fertnstert.2018.01.039","volume":"109","author":"BM Lyttle Schumacher","year":"2018","unstructured":"Lyttle Schumacher BM, Jukic AMZ, Steiner AZ. Antim\u00fcllerian hormone as a risk factor of miscarriage in naturally conceived pregnancies. Fertil Steril. 2018;109:1065\u201371.","journal-title":"Fertil Steril"},{"key":"1091_CR53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.rbmo.2018.04.039","volume":"37","author":"X Jiang","year":"2018","unstructured":"Jiang X, Yan J, Sheng Y, Sun M, Cui L, Chen Z-J. Low anti-M\u00fcllerian hormone concentration is associated with increased risk of embryonic aneuploidy in women of advanced age. Reprod Biomed Online. 2018;37:178\u201383.","journal-title":"Reprod Biomed Online"},{"key":"1091_CR54","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/humrep\/deaa008","volume":"35","author":"P Peuranp\u00e4\u00e4","year":"2020","unstructured":"Peuranp\u00e4\u00e4 P, Hautam\u00e4ki H, Halttunen-Nieminen M, Hyd\u00e9n-Granskog C, Tiitinen A. Low anti-M\u00fcllerian hormone level is not a risk factor for early pregnancy loss in IVF +\/- ICSI treatment. Hum Reprod. 2020;35:504\u201315.","journal-title":"Hum Reprod"},{"key":"1091_CR55","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.fertnstert.2017.07.001","volume":"108","author":"B Tarasconi","year":"2017","unstructured":"Tarasconi B, Tadros T, Ayoubi JM, Belloc S, de Ziegler D, Fanchin R. Serum antim\u00fcllerian hormone levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer. Fertil Steril. 2017;108:518\u201324.","journal-title":"Fertil Steril"},{"key":"1091_CR56","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.fertnstert.2007.03.080","volume":"89","author":"C Takahashi","year":"2008","unstructured":"Takahashi C, Fujito A, Kazuba M, Sugiyama R, Ito H, Isaka K. Anti-M\u00fcllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril. 2008;89:586\u201391.","journal-title":"Fertil Steril"},{"key":"1091_CR57","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S. Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update. 2016;22:709\u201324.","journal-title":"Hum Reprod Update"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01091-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-01091-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01091-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T17:23:42Z","timestamp":1683221022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-01091-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-01091-x","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the subjects have signed consent to the infertility treatment (ART French legislation). For this study, an informed consent was obtained from all subjects and\/or their legal guardians, and was approved by the Brest Institutional Review Board as an ancillary study of the authorization obtained on 2020 June 18 (reference B2020CE.43).The consents of each subject are available in their medical record and with the corresponding author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The manuscript has been read and approved by all authors. The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}